Bristol consolidating discovery research on East Coast, closing Seattle site.
Executive Summary
BRISTOL CONSOLIDATES DISCOVERY RESEARCH ON EAST COAST with the closing of its Seattle discovery research operation. Half of the 240 staff members at the Seattle immunology discovery operation will be invited to relocate to Princeton, N.J., Bristol-Myers Squibb announced April 23. The transition is expected to be completed by early 1998. The Seattle site was formerly the home of Oncogen, a joint venture of Syntex and Genetic Systems; Bristol became sole owner of the site in 1986 following its purchase of Genetic Systems.